Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics

1.5k papers and 25.7k indexed citations i.

About

The 1.5k papers published in Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics in the last decades have received a total of 25.7k indexed citations. Papers published in Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics usually cover Molecular Biology (984 papers), Cancer Research (552 papers) and Oncology (404 papers) specifically the topics of Cancer-related molecular mechanisms research (267 papers), MicroRNA in disease regulation (260 papers) and Circular RNAs in diseases (198 papers). The most active scholars publishing in Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics are Angela L. Tyner, Yong Feng, Kai Wang, Li Zhu, Juan Li, Hui Meng, Yun Bai, I. J. Fidler, Lei Xu and Michael S. Serfas.

In The Last Decade

Fields of papers published in Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers published in Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics.

Countries where authors publish in Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics

Since Specialization
Citations

This map shows the geographic impact of research published in Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore journals with similar magnitude of impact

Rankless by CCL
2025